Clinical Trials Directory

Trials / Conditions / Secondary Hyperparathyroidism Due to Renal Causes

Secondary Hyperparathyroidism Due to Renal Causes

6 registered clinical trials studyying Secondary Hyperparathyroidism Due to Renal Causes — 1 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingRetrospective Analysis of Quality of Life Changes in Patients Undergoing Parathyroidectomy for End-Stage Renal
NCT07151664
West China Hospital—
UnknownA Study on Prevention Strategies for CKD-SHPT and Related Complications Based on General Vitamin D Supplementa
NCT05549154
First Affiliated Hospital Xi'an Jiaotong UniversityN/A
TerminatedSafety, Efficacy, PK and PD of CTAP101 (Calcifediol) ER Capsules for SHPT in HD Patients VDI
NCT03602261
OPKO Health, Inc.Phase 2
CompletedRepeated-dose Safety, Efficacy, Pharmacokinetic and Pharmacodynamic of CTAP101, Immediate-release Calcifediol,
NCT03588884
OPKO Health, Inc.Phase 4
CompletedPulmonary Function, Voice and Swallowing Symptoms After Parathyroidectomy
NCT04267965
Chang Gung Memorial Hospital—
CompletedEfficacy and Safety of Paricalcitol in the Reduction of Secondary Hyperparathyroidism After Kidney Transplanta
NCT01939977
Fundación SenefroPhase 4